Staff editor

SynBalance at Vitafoods 2025: shaping the future of longevity through targeted probiotic solutions

An interview to SynBalance Marketing Manager, Silva Castegnaro on the latest clinically backed solutions shaping the future of biotics world.

Navigating Europe’s nutraceutical boom: strategies for sustainable success

With nearly half of European consumers taking supplements for general wellbeing, the potential for targeted innovation is vast, especially on “biotics” products.

Postbiotics: how heat-treated Lactobacilli (postbiotic) can improve gut-friendly Bifidobacteria growth

Postbiotics can selectively enhance beneficial microbes, offering a safe and effective microbiome-support strategy.

Europe boosts microbiome leadership with 13 new EMIH members

EMIH’s new members bring cutting-edge expertise in biotech, diagnostics, and patient advocacy, accelerating progress in microbiome-based healthcare.

Beyond the gut: how Zinereo Pharma is redefining reproductive health

Ana Nunes, Business Unit Director, on Zinereo’s science-backed mission to transform fertility through the microbiome.

Vitafoods Europe 2025: trends, innovations and market outlook

The report by MicrobiomePost distills key trends from Vitafoods Europe 2025, highlighting which cutting-edge innovations are shaping the nutraceutical and functional foods industry.

Riboflavin: the vitamin that helps good bacteria work better

Vitamins like riboflavin may support health not only through direct effects, but also by boosting beneficial microbial functions.

Clinically tested probiotics for common colds management designed by SynBalance

A new scientific publication on the beneficial effect of probiotics on cold symptoms relief, immune response enhancement, and quality of life in healthy adults during winter seasons.

Next Generation Biotics: unveiling new evidence and applications at the Probiotic, Prebiotic and New Food Congress

At the upcoming Probiotic, Prebiotic and New Food Congress, Professor Willem de Vos, University of Helsinki, will explore emerging insights into the role of dietary fibers and their transformation into…

Microbiome therapeutics take a bold step into ALS: MaaT Pharma’s MaaT033 shows promise in Phase 1b study

MaaT Pharma’s venture marks an innovative and hopeful chapter in the ongoing effort to fight neurodegeneration.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top